MANNKIND CORP(MNKD)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

MANNKIND CORP (MNKD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MNKD at 37.2/100 on a 32-signal composite quality model, placing it at rank #2,241 of 2,960 stocks — the bottom half of the AI-ranked universe. MNKD scores in the top quartile across revenue growth (87.1). Areas of concern include profitability (17.3) and institutional flow (19.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 20.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), MANNKIND CORP reports quarterly revenue of $109.4M, net income of $-19.0M, an operating margin of -0.3%. Top institutional holders of MNKD by reported 13-F value include BlackRock, Rubric Capital Management, STATE STREET, based on the most recent SEC filings. MNKD trades on the Nasdaq exchange and files with the SEC under CIK 899460. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MNKD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MANNKIND CORP directly from SEC EDGAR.